SCHEMBL16355221

SCHEMBL16355221

CCN(CC)c1ccc(NC(=O)c2cccc(CSCCOCCC(=O)N(CCO)CCO)c2)c(-c2cc(C(=O)NCc3cccc(C(F)(F)F)c3)ccn2)c1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC34A2 O95436 1/20 0.84
ROCK2 O75116 1/20 0.37
ROCK1 Q13464 1/20 0.37
SCD O00767 3/20 0.36
GPR52 Q9Y2T5 4/20 0.36
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C19 P33261 2/20 0.34
MLYCD O95822 1/20 0.34
GFER P55789 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15432785 0.99 SLC34A2 (0.85) SLC34A2ROCK2ROCK1SCDGPR52
SCHEMBL16355224 0.92 SLC34A2 (0.99) SLC34A2ROCK2ROCK1SCDGPR52
SCHEMBL15432781 0.91 SLC34A2 (1.00) SLC34A2ROCK2ROCK1SCDGPR52
SCHEMBL15432774 0.91 SLC34A2 (1.00) SLC34A2ROCK2ROCK1SCDGPR52
SCHEMBL46830 0.91 SLC34A2 (0.89) SLC34A2ROCK2ROCK1SCDGPR52
SCHEMBL16355222 0.90 SLC34A2 (0.83) SLC34A2ROCK2ROCK1SCDGPR52
SCHEMBL15432776 0.89 SLC34A2 (0.84) SLC34A2ROCK2ROCK1SCDGPR52
SCHEMBL16355223 0.89 SLC34A2 (0.84) SLC34A2ROCK2ROCK1SCDGPR52
SCHEMBL15432780 0.88 SLC34A2 (0.84) SLC34A2ROCK2ROCK1SCDGPR52
SCHEMBL16355211 0.87 SLC34A2 (0.64) SLC34A2ROCK2ROCK1GPR52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9301951-B2 Compounds and methods for inhibiting phosphate transport ARDELYX, INC. (US) 2016-04-05 US disclosed
US-20150164876-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. 2015-06-18 US disclosed
US-8916569-B2 Compounds and methods for inhibiting phosphate transport ARDELYX, INC. (US) 2014-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150164876-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT SLC34A2, SLC34A1, SLC10A2 SLC34A2 1/4885ROCK2 2489/4885ROCK1 1903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.